Guardion Health Sciences Inc

Guardion Health Sciences, Inc.is a clinical nutrition and diagnostics company, which develops medical foods and medical devices in the ocular health space and develops nutraceutical products to provide supportive health benefits to consumers. The company was founded by Michael Favish in 2009 and is headquartered in Houston, TX.

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Guardion Health Sciences, Inc. engages in the development and distribution of clinically supported dietary supplements and medical foods. The firm also offers science-based products and devices designed to support healthcare professionals, providers, patients, and consumers. The company was founded by Michael Favish in December 2009 and is headquartered in Houston, TX.

HOUSTON, June 01, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI) announced an agreement with OmegaQuant Laboratories (“OmegaQuant”) to provide Guardion with analytic testing and laboratory support services for current and future products. Guardion is a clinical nutrition company that offers a portfolio of science-based, clinically-developed products that are designed to support the health needs of consumers, healthcare professionals and providers and their patients.

Guardion Health Sciences Announces Agreement with OmegaQuant Laboratories

SciSparc Ltd

The Very Good Food Co

Which penny stocks are you watching today? The post Best Penny Stocks to Watch as the Market Turns Bullish Today appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Best Penny Stocks to Watch as the Market Turns Bullish Today

Consumers May Now Purchase Viactiv Omega Boost 1,200 mg Omega-3 Gel Bites Directly from Amazon

Guardion Health Sciences Announces New Viactiv Omega Boost Gel Bites Now Available for Purchase on Amazon

Viactiv® Generated Net Revenues of approximately $2.3 Million or 95% of Net Revenues for the Quarter Ended March 31, 2022 Viactiv® Generated Net Revenues of approximately $2.3 Million or 95% of Net Revenues for the Quarter Ended March 31, 2022

Guardion Health Sciences Announces Financial Results for the Quarter Ended March 31, 2022

HOUSTON, May 03, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI), a clinical nutrition company that develops clinically supported nutrition, medical foods, and supplements, announces today that Chief Executive Officer Bret Scholtes will present a corporate overview at the Planet MicroCap Showcase 2022. The conference is being held on May 3 – 5, 2022 at The Bally's Hotel & Casino in Las Vegas, NV.

Guardion Health Sciences to Present at the Planet MicroCap Showcase 2022

Consumers May Now Purchase Viactiv® Omega Boost Directly from Viactiv.com

Guardion Health Sciences Announces New Viactiv® Omega Boost Gel Bites Now Available for Purchase Via Viactiv® Shopify Store

June 2021 Acquisition of Viactiv® Brand and Business Changed Operational Focus of Company and Materially Impacted 2021 Revenues, Operations and Financial Results

Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2021

HOUSTON, March 11, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI), a clinical nutrition company that develops clinically supported nutrition, medical foods, and supplements, announces today that Chief Executive Officer Bret Scholtes will participate in a fireside chat with Scott Henry, Managing Director and Senior Research Analyst at Roth Capital Partners during the 34th Annual Roth Conference. The conference is being held on March 13 – 15, 2022, at The Ritz Carlton, Laguna Niguel located in Dana Point, CA.

Guardion Health Sciences to Participate in Fireside Chat at the 34th Annual Roth Conference

Kiromic Biopharma

Powerbridge Technologies Co Ltd

Exicure Inc

Penny stocks to watch under $1 this week. The post 4 Top Penny Stocks To Buy For Under $1 This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

4 Top Penny Stocks To Buy For Under $1 This Week

CooTek (Cayman) Inc - ADR

Kiora Pharmaceuticals

Northern Dynasty Minerals

Hot penny stocks to buy for under $1. Are they worth it in March 2022?

Hot Penny Stocks To Buy For Under $1 In March 2022

HOUSTON, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (NASDAQ:GHSI) (“Guardion” or the “Company”), a clinical nutrition company that develops clinically supported nutrition, medical foods, and supplements, today announced the closing of a previously announced public offering of 37,000,000 shares of its common stock (or common stock equivalents in lieu thereof), Class A warrants to purchase up to 37,000,000 shares of its common stock and Class B warrants to purchase up to 37,000,000 shares of its common stock for gross proceeds of approximately $11.1 million prior to deducting placement agent fees and offering expenses. The price to the public for a share of common stock (or common stock equivalents in lieu thereof) and related Class A warrant and Class B warrant was $0.30. The Class A warrants have an exercise price of $0.37 per share and expire on the fifth anniversary of the date of issuance. The Class B warrants have an exercise price of $0.37 per share and expire eighteen months from the date of issuance.

Guardion Health Sciences, Inc. Announces Closing of $11 Million Public Offering

HOUSTON, Feb. 18, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (NASDAQ:GHSI) (“Guardion” or the “Company”), a clinical nutrition company that develops clinically supported nutrition, medical foods, and supplements, today announced the pricing of a previously announced public offering of 37,000,000 shares of its common stock (or common stock equivalents in lieu thereof), Class A warrants to purchase up to 37,000,000 shares of its common stock and Class B warrants to purchase up to 37,000,000 shares of its common stock for gross proceeds of approximately $11.1 million prior to deducting placement agent fees and offering expenses. The price to the public for a share of common stock (or common stock equivalents in lieu thereof) and related Class A warrant and Class B warrant was $0.30. The Class A warrants have an exercise price of $0.37 per share and expire on the fifth anniversary of the date of issuance. The Class B warrants have an exercise price of $0.37 per share and expire eighteen months from the date of issuance.

Guardion Health Sciences, Inc. Announces Pricing of $11 Million Public Offering

New e-commerce venue to offer all Viactiv products and additional educational content to enhance user experience New e-commerce venue to offer all Viactiv products and additional educational content to enhance user experience

Guardion Health Sciences Launches New Online Store for Viactiv

Management Anticipates $300,000+ Reduction in Annual Operating Costs Management Anticipates $300,000+ Reduction in Annual Operating Costs

Guardion Health Sciences to Wind Down VectorVision Business Operations and Focus on Exploiting VectorVision Intellectual Property

HOUSTON, Dec. 16, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), a clinical nutrition and diagnostics company that develops clinically supported nutrition, medical foods, supplements, and medical devices, issued the following Letter to Shareholders:

Guardion Health Sciences Issues Letter to Shareholders

$3,000,000+ Sales from Viactiv® Products During the Quarter $3,000,000+ Sales from Viactiv® Products During the Quarter

Guardion Health Sciences Announces Financial Results for the Three Months Ended September 30, 2021

Guardion Health Science (GHSI) stock is taking off on Wednesday thanks to a presentation taking place today and heavy trading. The post GHSI Stock: 12 Things to Know About Guardion Health Science as Shares Rocket appeared first on InvestorPlace.

GHSI Stock: 12 Things to Know About Guardion Health Science as Shares Rocket

HOUSTON, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition and diagnostics company that develops clinically supported nutrition, medical foods, supplements, and medical devices, urges stockholders to vote their shares for the Company's Annual Meeting of Stockholders on October 22, 2021 by 11:59PM ET on October 21, 2021.

Guardion Health Sciences Stockholders Urged to Vote Their Shares for October 22, 2021 Annual Meeting

HOUSTON, Oct. 05, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition and diagnostics company that develops clinically supported nutrition, medical foods, supplements, and medical devices, announces today that Chief Executive Officer Bret Scholtes will present a corporate overview at the 14th Annual LD Micro Main Event Conference at the Luxe Sunset Bel-Air in Los Angeles from October 12 – 14, 2021.

Guardion Health Sciences to Present at the LD Micro Main Event Conference

Corporate Update and Overview of Growth Plans Also Provided Corporate Update and Overview of Growth Plans Also Provided

Guardion Health Sciences Announces Financial Results for the Three Months Ended June 30, 2021, including $1,000,000+ of Sales from Viactiv® Products in the First Month of Guardion's Ownership

SAN DIEGO, July 22, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition and diagnostics company that develops clinically supported nutrition, supplements, medical foods and medical devices, announced it will be an exhibitor at the 2021 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting at The Mandalay Bay Convention Center, Las Vegas, Nevada, from July 23 - 27, 2021. The Company can be found in the exhibit hall at booth #2229.

Guardion Health Sciences to Exhibit at the American Society of Cataract and Refractive Surgery Annual Meeting

Guardion Health Sciences Inc. (NASDAQ: GHSI) is confident that its recent acquisition of Activ Nutritional LLC will be a strong catalyst for growth. The company successfully entered into an equity purchase agreement with Adare Pharmaceuticals Inc. in June this year to acquire all the equity of Activ Nutritional for $26 million.

Acquiring Activ Nutritional Is Perfect for Growth, Says Guardion Health Sciences

SAN DIEGO, June 14, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition and diagnostics company that develops clinically supported nutrition, supplements, medical foods and medical devices, today announced that Guardion is being added to the Russell 3000 Index. The inclusion of Guardion in the Russell 3000 Index will take place at the conclusion of the 2021 Russell Indexes' annual reconstitution, which is expected to be effective after the U.S. market opens on June 28, 2021, according to a preliminary list of additions posted on June 4, 2021.

Guardion Health Sciences to Be Added to the Russell 3000 Index

Proven Leader of Viactiv Brand to Oversee Ramp Up and Commercial Activities at Guardion Proven Leader of Viactiv Brand to Oversee Ramp Up and Commercial Activities at Guardion

Guardion Health Sciences Announces Appointment of Craig J. Sheehan as Chief Commercial Officer

Acquisition to Transform and Strengthen Guardion's  Clinical Nutrition Product Portfolio

Guardion Health Sciences Broadens Clinical Nutrition Product Offerings by Closing Acquisition of Activ Nutritional, which owns the Science Backed, Revenue-Generating Viactiv® Product Line, from Adare Pharmaceuticals

News for Guardion Health Sciences Inc Stock (GHSI)